Literature DB >> 17617371

Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations.

Alberto Valbuena1, Inmaculada López-Sánchez, Francisco M Vega, Ana Sevilla, Marta Sanz-García, Sandra Blanco, Pedro A Lazo.   

Abstract

The human VRK1 is a new ser-thr kinase expressed in many cell types. VRK1 is a regulator of p53 and other transcription factors related with cellular responses to stress. The human VRK1 protein has a dominant epitope located in its C-terminal region, between residues 333 and 396, which is detected by different antibodies. All the antibodies detect the same protein in immunoblots and immunoprecipitations. But the antibodies have a different reactivity when a single aminoacid substitution in T355, mimicking phosphorylation, is introduced next to the nuclear localization signal. These differences in reactivity permit the identification of different intracellular subpopulations. Most of the intracellular VRK1 protein is nuclear, but in some cells it is also detected in the cytosol, depending on the type of tissue. These different locations are detected by immunohistochemistry of human biopsies and immunofluorescence of cell lines. Some antibodies identify a subpopulation within the vesicular system, particularly in the Golgi apparatus. The different reactivity of the VRK1 protein indicates that this protein has a subcellular localization that can be regulated, thus adding an additional level of regulatory complexity to the VRK1 protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617371     DOI: 10.1016/j.abb.2007.06.005

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

1.  Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation.

Authors:  Inmaculada López-Sánchez; Marta Sanz-García; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

2.  Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage.

Authors:  Marta Sanz-García; Diana M Monsalve; Ana Sevilla; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

3.  Functional disruption of the moloney murine leukemia virus preintegration complex by vaccinia-related kinases.

Authors:  Yasutsugu Suzuki; Kanako Ogawa; Yoshio Koyanagi; Youichi Suzuki
Journal:  J Biol Chem       Date:  2010-05-28       Impact factor: 5.157

4.  A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection.

Authors:  Nicola J MacLaine; Bodil Oster; Bettina Bundgaard; Jennifer A Fraser; Carolyn Buckner; Pedro A Lazo; David W Meek; Per Höllsberg; Ted R Hupp
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

5.  Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia.

Authors:  Matthew S Wiebe; R Jeremy Nichols; Tyler P Molitor; Jill K Lindgren; Paula Traktman
Journal:  Biol Reprod       Date:  2009-08-19       Impact factor: 4.285

6.  Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene.

Authors:  Paul Renbaum; Efrat Kellerman; Ranit Jaron; Dan Geiger; Reeval Segel; Ming Lee; Mary Claire King; Ephrat Levy-Lahad
Journal:  Am J Hum Genet       Date:  2009-07-30       Impact factor: 11.025

7.  Differential inhibitor sensitivity between human kinases VRK1 and VRK2.

Authors:  Marta Vázquez-Cedeira; Iria Barcia-Sanjurjo; Marta Sanz-García; Ramiro Barcia; Pedro A Lazo
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

8.  Vaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cells.

Authors:  Yoon Ha Choi; Choon-Ho Park; Wanil Kim; Hua Ling; Aram Kang; Matthew Wook Chang; Sun-Kyoung Im; Hyun-Woo Jeong; Young-Yun Kong; Kyong-Tai Kim
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

9.  Downregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway.

Authors:  Alberto Valbuena; Susana Castro-Obregón; Pedro A Lazo
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

10.  Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals.

Authors:  Iria Barcia-Sanjurjo; Marta Vázquez-Cedeira; Ramiro Barcia; Pedro A Lazo
Journal:  J Biol Inorg Chem       Date:  2013-03-13       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.